[1] Talal AH, Perlman DC, Des Jarlais DC. Quality of care in patients with chronic hepatitis C virus infection. Ann Intern Med, 2011,154: 213-214.
[2] Pattullo V, Heathcote EJ, Wong DK. Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C. Hepatol Int, 2010, 4: 723-731.
[3] Aoki YH, Ohkoshi S, Yamagiwa S, et al. Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C. Hepatol Res, 2011, 41: 118-125.
[4] Tsubota A, Fujise K, Namiki Y, et al. Peginterferon and ribavirin treatment for hepatitis C virus infection. World J Gastroenterol, 2011, 17: 419-432.
[5] Trapero-Marugán M,Mendoza J, Chaparro M, et al. Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin. World J Gastroenterol, 2011, 17: 493-498.
[6] Kamal SM, Ahmed A, Mahmoud S, et al. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis. Liver Int, 2011, 31: 401-411.
[7] 福军亮,王福生.慢性乙型肝炎患者的个体化免疫调节治疗.中华检验医学杂志,2011,34:300-304.
[8] 覃小梅,谭晓明,秦玉兰. 乙型肝炎患者免疫球蛋白检验的临床意义.临床和实验医学杂志,2011,10: 702-703.
[9] 张英英.聚乙二醇干扰素α-2a与普通干扰素α-2b联合利巴韦林抗丙肝病毒治疗的疗效比较及抗病毒疗效预测因素分析. 河南郑州:郑州大学,2013.
[10] Song YJ, Lee YJ, Choi BJ, et al. Tailored therapy for treatment-naive chronic hepatitis C with pegylated Interferon-α and ribavirin: real practiceexperience. Korean J Hepatol, 2010, 16: S57.
[11] Sulkowski MS, Cooper C, Hunyady B, et al. Management of adverse effectsof Peg-IFN and ribavirin therapy for hepatitis C. Nat Rev Gastroenterol Hepatol, 2011, 8: 212-223.
[12] Nair Kesavachandran C, Haamann F, Nienhaus A. Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis. PloS one, 2013, 8: e55364.
[13] 晏双龙.干扰素联合利巴韦林治疗慢性丙型肝炎的疗效分析. 广西南宁:广西医科大学,2014.
[14] 杨艳杰,王福,郭艳玲,等.长效干扰素联合利巴韦林治疗慢性丙型肝炎疗效观察.现代中西医结合杂志,2011,20:2998-3000.
[15] 张泽敏,于兰芳,李一鸣,等.聚乙二醇干扰素α-2a联合利巴韦林联合熊去氧胆酸治疗慢性丙型肝炎的临床疗效评价.世界华人消化杂志,2014,22:1005-1009. |
